Edition:
United States

Egyptian International Pharmaceuticals Industries Co SAE (PHAR.CA)

PHAR.CA on Cairo Stock Exchange

141.99EGP
19 Apr 2018
Change (% chg)

£0.00 (+0.00%)
Prev Close
£141.99
Open
£141.50
Day's High
£141.99
Day's Low
£141.50
Volume
43,000
Avg. Vol
54,357
52-wk High
£153.00
52-wk Low
£100.50

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 2,885.50 2,965.00 2,806.00 3,156.50
Year Ending Dec-19 3 3,340.77 3,690.31 3,141.00 3,617.00
Earnings (per share)
Year Ending Dec-18 2 8.86 8.93 8.80 8.33
Year Ending Dec-19 3 11.40 14.24 9.60 9.14
Sales and Profit Figures in Egypt Pound (EGP);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 16.36 30.65 33.25
P/E High - Last 5 Yrs. 18.19 40.51 45.98
P/E Low - Last 5 Yrs. 10.38 24.06 24.86
Beta 0.22 0.81 0.80
Price to Sales (TTM) 4.45 4.62 7.20
Price to Book (MRQ) 4.46 4.03 5.06
Price to Tangible Book (MRQ) 4.52 4.93 6.69
Price to Cash Flow (TTM) 13.41 22.24 25.20
% Owned Institutions -- 1.18 2.26

Dividends

  Company industry sector
Dividend Yield 2.85 1.62 1.53
Dividend Yield - 5 Year Avg 4.11 0.74 0.76
Dividend 5 Year Growth Rate 8.45 2.75 3.96
Payout Ratio(TTM) 51.86 20.50 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 30.96 6.93 8.73
Sales (TTM) vs TTM 1 Yr. Ago 28.34 9.93 11.30
Sales - 5 Yr. Growth Rate 15.03 7.66 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.20 19.48 22.52
EPS (TTM) vs TTM 1 Yr. Ago 41.17 -- --
EPS - 5 Yr. Growth Rate 16.46 8.96 10.26
Capital Spending - 5 Yr. Growth Rate -8.25 9.68 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.74 2.52 2.53
Current Ratio (MRQ) 3.08 3.60 3.61
LT Debt to Equity (MRQ) 0.00 8.83 11.52
Total Debt to Equity (MRQ) 5.41 11.17 14.21
Interest Coverage (TTM) -- 36.10 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 37.97 54.75 54.09
Gross Margin - 5 Yr. Avg. 35.14 52.16 52.20
EBITD Margin (TTM) 37.06 -- --
EBITD - 5 Yr. Avg 36.03 18.42 15.86
Operating Margin (TTM) 28.64 12.77 3.97
Operating Margin - 5 Yr. Avg. 28.26 14.17 11.17
Pre-Tax Margin (TTM) 35.62 13.01 4.62
Pre-Tax Margin - 5 Yr. Avg. 32.10 14.52 11.49
Net Profit Margin (TTM) 27.26 9.42 1.24
Net Profit Margin - 5 Yr. Avg. 24.56 10.85 7.83
Effective Tax Rate (TTM) 23.48 22.47 31.24
Effective Tax Rate - 5 Yr. Avg. 23.46 23.66 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 912,108,786 806,826,037
Net Income/Employee (TTM) -- 107,196,444 94,789,739
Receivable Turnover (TTM) 8.74 5.59 5.54
Inventory Turnover (TTM) 1.88 2.55 3.44
Asset Turnover (TTM) 0.83 0.91 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 22.52 10.90 10.47
Return on Assets - 5 Yr. Avg. 17.28 12.09 11.49
Return on Investment (TTM) 30.70 13.53 13.13
Return on Investment - 5 Yr. Avg. 24.69 15.63 14.88
Return on Equity (TTM) 31.59 15.22 14.96
Return on Equity - 5 Yr. Avg. 25.55 16.82 16.18
  1 Year 3 Year 5 Year
Sales % 28.34 17.00 15.03
EPS (TTM) % 41.15 26.20 16.46
Dividend % 28.57 10.89 8.45
Note: Units in Millions of US Dollars

Performance for Egyptian International Pharmaceuticals Industries Co SAE

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.16%
# of Holders: 21
Total Shares Held: 8,063,319
3 Mo. Net Change: -8,610
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.